Bolivia registers Sputnik V vaccine

09:21, 07 January 2021
Bolivia registers Sputnik V vaccine Photo:

Bolivia has granted emergency approval for use of Russia’s Sputnik vaccine against COVID, Reuters reports referring to the Russian Direct Investment Fund (RDIF).

The vaccine was registered by the Bolivian regulator based on the results of Phase III clinical trials in Russia, without additional trials in Bolivia, RDIF said in a statement.

RDIF said on Dec. 30 it had agreed to supply Bolivia with enough of its two-dose Sputnik V coronavirus vaccine to vaccinate 2.6 million people. reported earlier that at least 92 percent of patients vaccinated by Russia’s Sputnik V received complete protection from COVID, said Alexander Gintsburg, head of the Gamaleya Center.